Patents by Inventor Ian George Barr

Ian George Barr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8784831
    Abstract: The present invention provides an antigenic composition, the composition comprising at least one recombinant protein. The recombinant protein comprises at least one epitope. The epitope is reactive with an antibody which is reactive with a polypeptide having the sequence set out in SEQ. ID. NO. 3 or SEQ. ID. NO. 5. The invention also provides methods and compositions for the production of the recombinant protein. Also provided are methods for the diagnosis, treatment and prevention of P. gingivalis infection.
    Type: Grant
    Filed: August 3, 2012
    Date of Patent: July 22, 2014
    Assignees: CSL Limited, The University of Melbourne
    Inventors: Eric Charles Reynolds, Nada Slakeski, Chao Guang Chen, Ian George Barr
  • Publication number: 20130164298
    Abstract: The present invention provides an antigenic composition, the composition comprising at least one recombinant protein. The recombinant protein comprises at least one epitope. The epitope is reactive with an antibody which is reactive with a polypeptide having the sequence set out in SEQ. ID. NO. 3 or SEQ. ID. NO. 5. The invention also provides methods and compositions for the production of the recombinant protein. Also provided are methods for the diagnosis, treatment and prevention of P. gingivalis infection.
    Type: Application
    Filed: August 3, 2012
    Publication date: June 27, 2013
    Inventors: Eric Charles Reynolds, Nada Slakeski, Chao Guang Chen, Ian George Barr
  • Patent number: 7419671
    Abstract: The present invention provides an antigenic composition, the composition comprising at least one recombinant protein. The recombinant protein comprises at least one epitope. The epitope is reactive with an antibody which is reactive with a polypeptide having the sequence set out in SEQ. ID. NO. 3 or SEQ. ID. NO. 5. The invention also provides methods and compositions for the production of the recombinant protein. Also provided are methods for the diagnosis, treatment and prevention of P. gingivalis infection.
    Type: Grant
    Filed: June 18, 2002
    Date of Patent: September 2, 2008
    Assignees: CSL Limited, The University of Melbourne
    Inventors: Eric Charles Reynolds, Nada Slakeski, Chao Guang Chen, Ian George Barr
  • Publication number: 20080175867
    Abstract: The present invention provides an antigenic composition, the composition comprising at least one recombinant protein. The recombinant protein comprises at least one epitope. The epitope is reactive with an antibody which is reactive with a polypeptide having the sequence set out in SEQ. ID. NO. 3 or SEQ. ID. NO. 5. The invention also provides methods and compositions for the production of the recombinant protein. Also provided are methods for the diagnosis, treatment and prevention of P. gingivalis infection.
    Type: Application
    Filed: March 27, 2007
    Publication date: July 24, 2008
    Applicants: CSL Limited, The University of Melbourne
    Inventors: Eric C. Reynolds, Nada Slakeski, Chao Guang Chen, Ian George Barr
  • Patent number: 7204991
    Abstract: The present invention relates to soluble P. gingivalis polypeptides derived from PG32 and PG33 and to polynucleotides encoding these polypeptides. The P. gingivalis polypeptides and nucleotides can be used in compositions for use in raising an immune response in a subject against P. gingivalis and treating or preventing or reducing the severity of the condition known as periodontitis or in other conditions related to infection with P. gingivalis.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: April 17, 2007
    Assignee: CSL Limited
    Inventors: Ian George Barr, Larissa Czajkowski, Bruce Carter Ross
  • Publication number: 20030232022
    Abstract: The present invention provides an antigenic composition, the composition comprising at least one recombinant protein. The recombinant protein comprises at least one epitope. The epitope is reactive with an antibody which is reactive with a polypeptide having the sequence set out in SEQ. ID. NO. 3 or SEQ. ID. NO. 5. The invention also provides methods and compositions for the production of the recombinant protein. Also provided are methods for the diagnosis, treatment and prevention of P. gingivalis infection.
    Type: Application
    Filed: June 18, 2002
    Publication date: December 18, 2003
    Inventors: Eric Charles Reynolds, Nada Slakeski, Guang Chao Chen, Ian George Barr
  • Patent number: 6663873
    Abstract: An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the lipopolysaccharide (LPS) of Helicobacter bacteria, particularly the LPS of H. pylori or H. felis, or an immunogenic fragment thereof.
    Type: Grant
    Filed: August 9, 1996
    Date of Patent: December 16, 2003
    Assignee: CSL
    Inventors: Christopher Vincent Doidge, Adrian Lee, Fiona Jane Buck, Elizabeth Pietrzykowski, Charles Alexander Quinn, Ian George Barr, Michael John Kleinig
  • Publication number: 20030215402
    Abstract: The present invention relates to soluble P. gingivalis polypeptides derived from PG32 and PG33 and to polynucleotides encoding these polypeptides. The P. gingivalis polypeptides and nucleotides can be used in compositions for use in raising an immune response in a subject against P. gingivalis and treating or preventing or reducing the severity of the condition known as periodontitis or in other conditions related to infection with P. gingivalis.
    Type: Application
    Filed: October 28, 2002
    Publication date: November 20, 2003
    Inventors: Ian George Barr, Larissa Czajkowski, Bruce Carter Ross